Total Payments
$9,275
2024 Payments
$392.03
Companies
49
Transactions
521
Medicare Patients
405
Medicare Billing
$51,126
Payment Breakdown by Category
Food & Beverage$7,925 (85.4%)
Research$1,345 (14.5%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,925 | 513 | 85.4% |
| Unspecified | $1,345 | 7 | 14.5% |
| Education | $5.00 | 1 | 0.1% |
Payments by Type
General
$7,930
514 transactions
Research
$1,345
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,677 | 27 | $0 (2023) |
| Novo Nordisk Inc | $907.97 | 69 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $778.57 | 51 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $556.70 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $545.72 | 36 | $0 (2023) |
| GlaxoSmithKline, LLC. | $462.67 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $445.77 | 27 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $374.55 | 26 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $334.88 | 22 | $0 (2022) |
| Lilly USA, LLC | $266.25 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.03 | 19 | Novo Nordisk Inc ($58.04) |
| 2023 | $840.76 | 50 | Bayer Healthcare Pharmaceuticals Inc. ($131.56) |
| 2022 | $1,107 | 58 | Bayer HealthCare Pharmaceuticals Inc. ($181.25) |
| 2021 | $1,055 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($185.30) |
| 2020 | $805.54 | 54 | AstraZeneca Pharmaceuticals LP ($201.00) |
| 2019 | $2,476 | 84 | AbbVie, Inc. ($1,360) |
| 2018 | $1,330 | 87 | Novo Nordisk Inc ($244.36) |
| 2017 | $1,268 | 106 | Novo Nordisk Inc ($232.89) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Endocrinology | ||||||
| 09/27/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/13/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Hematology | ||||||
| 05/13/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Hematology | ||||||
| 05/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: UROLOGY | ||||||
| 04/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: VACCINES | ||||||
| 03/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardio-renal | ||||||
| 03/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Biological | ||||||
| 01/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Biological | ||||||
| 12/07/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Hematology | ||||||
| 11/29/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Inflammation | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 11/20/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: GI | ||||||
| 11/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Biological | ||||||
| 10/25/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M16-100 | AbbVie, Inc. | $1,345 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 99 | 259 | $42,462 | $13,686 |
| 2022 | 5 | 105 | 351 | $34,983 | $17,505 |
| 2021 | 6 | 125 | 289 | $25,562 | $13,262 |
| 2020 | 3 | 76 | 188 | $17,912 | $6,674 |
Total Patients
405
Total Services
1,087
Medicare Billing
$51,126
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 124 | $32,240 | $9,119 | 28.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 38 | $3,364 | $1,615 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,450 | $1,588 | 46.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 36 | $2,628 | $1,212 | 46.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 30 | $420.00 | $91.13 | 21.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 18 | $360.00 | $61.38 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 141 | $25,400 | $11,522 | 45.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 79 | $4,748 | $3,257 | 68.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 69 | $3,841 | $2,527 | 65.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 17 | 41 | $574.00 | $127.08 | 22.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 21 | $420.00 | $72.16 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 98 | $12,250 | $4,651 | 38.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 43 | $6,020 | $3,920 | 65.1% |
| 99489 | Complex chronic care management services, each additional 60 minutes clinical staff time per calendar month | Office | 2021 | 17 | 71 | $3,550 | $2,380 | 67.0% |
| 99487 | Complex chronic care management services, first 60 minutes clinical staff time per calendar month | Office | 2021 | 17 | 18 | $1,800 | $1,237 | 68.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 12 | 31 | $1,550 | $981.77 | 63.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 14 | 28 | $392.00 | $91.84 | 23.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 119 | $13,950 | $4,798 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 25 | $3,346 | $1,733 | 51.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 20 | 44 | $616.00 | $143.07 | 23.2% |
About Dr. Gerald Hill, M.D
Dr. Gerald Hill, M.D is a Family Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114971009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Hill, M.D has received a total of $9,275 in payments from pharmaceutical and medical device companies, with $392.03 received in 2024. These payments were reported across 521 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,925).
As a Medicare-enrolled provider, Hill has provided services to 405 Medicare beneficiaries, totaling 1,087 services with total Medicare billing of $51,126. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Greensboro, NC
- Active Since 05/22/2006
- Last Updated 07/12/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114971009
Products in Payments
- Androgel (Drug) $1,355
- ENTRESTO (Drug) $459.94
- JARDIANCE (Drug) $399.82
- Kerendia (Drug) $374.55
- Victoza (Drug) $362.11
- FARXIGA (Drug) $296.48
- GEMTESA (Drug) $242.60
- SYMBICORT (Drug) $231.28
- Ozempic (Drug) $216.01
- CYCLOSET (Drug) $168.41
- VRAYLAR (Drug) $163.80
- ANORO (Drug) $160.66
- TRULICITY (Drug) $156.56
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $156.08
- TRELEGY ELLIPTA (Drug) $153.61
- TOUJEO (Drug) $153.56
- XARELTO (Drug) $142.73
- Livalo (Drug) $139.30
- LONHALA MAGNAIR (Drug) $123.03
- Veozah (Drug) $120.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greensboro
Mrs. Veita Bland, M.d, M.D
Family Medicine — Payments: $53,051
Family Medicine $53,051
Alexander Murray, M.d, M.D
Family Medicine — Payments: $48,455
Family Medicine $48,455
Dr. Robert Cowles, M.d, M.D
Family Medicine — Payments: $31,631
Family Medicine $31,631
Dr. John Lalonde, M.d, M.D
Family Medicine — Payments: $16,294
Family Medicine $16,294
Dana Collins, D.o, D.O
Family Medicine — Payments: $12,715
Family Medicine $12,715
Dr. Brent Greenberg, M.d, M.D
Family Medicine — Payments: $10,958
Family Medicine $10,958